医学
癌症
内科学
肿瘤科
毒性
细胞毒性T细胞
化疗
癌症治疗
放射治疗
梅德林
免疫疗法
癌症治疗
临床试验
作者
Noriko Wada,YUKINORI KUROKAWA,TSUYOSHI TAKAHASHI,Takuro Saito,Takaomi Hagi,Shigeto Nakai,Kota Momose,Kotaro Yamashita,KOJI TANAKA,TOMOKI MAKINO,Hidetoshi Eguchi,YUICHIRO DOKI,TAROH SATOH
出处
期刊：Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期：2026-01-30
卷期号：46 (2): 949-961
标识
DOI：10.21873/anticanres.18001
摘要
Sustained anti-HER2 therapy was strongly associated with longer survival. Adjusting the cytotoxic partner to manage toxicity may help patients continue trastuzumab-based treatment and achieve better outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
cat
Nole
昏睡的蟠桃
Kao
Criminology34
aajhajkahna
张欢馨
GingerF
东方元语
OK
huanhuanhuan
ming2026
dde
sagitar
学术文献互助
贪玩的秋柔
三年两篇以上一区SCI
14and15
大刘
皖公网安备34019202002308
